Pituitary adenomas in young patients: when should we consider a genetic predisposition?

References

• Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab.91(12), 4769–4775 (2006).
   PubMed Web of Science ®Google Scholar
• Kunwar S, Wilson CB. Pediatric pituitary adenomas. J. Clin. Endocrinol. Metab.84(12), 4385–4389 (1999).
   Google Scholar
• Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J. Clin. Endocrinol. Metab.84(12), 4317–4323 (1999).
   PubMed Web of Science ®Google Scholar
• Keil MF, Stratakis CA. Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics. Expert Rev. Neurother.8(4), 563–574 (2008).
   PubMedGoogle Scholar
• Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu. Rev. Pathol,4, 97–126 (2009).
   PubMed Web of Science ®Google Scholar
• Tichomirowa MA, Daly AF, Beckers A. Familial pituitary adenomas. J. Intern. Med.266(1), 5–18 (2009).
   Google Scholar
• Pellegata NS, Quintanilla-Martinez L, Siggelkow H et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc. Natl Acad. Sci. USA103(42), 15558–15563 (2006).
   PubMed Web of Science ®Google Scholar
• Georgitsi M, Raitila A, Karhu A et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia J. Clin. Endocrinol. Metab.92(8), 3321–3325 (2007).
   PubMed Web of Science ®Google Scholar
• Valdes-Socin H, Poncin J, Stevens V, Stevenaert A, Beckers A. Adénomes hypophysaires familiaux isolés non liés avec la mutation somatique NEM-1. Suivi de 27 patients. Ann. Endocrinol. (Paris)61, 301 (2000).
   Google Scholar
• Valdes-Socin H, Jaffrain Rea ML, Tamburrano G et al. Familial isolated pituitary tumors: clinical and molecular studies in 80 patients. Presented at: 84th Annual Meeting of the Endocrine Society, San Francisco, CA, USA, 19–22 June 2002.
   Google Scholar
• Daly AF, Jaffrain-Rea ML, Beckers A. Clinical and genetic features of familial pituitary adenomas. Horm. Metab. Research37(6), 347–354 (2005).
   Google Scholar
• Beckers A. Familial isolated pituitary adenomas. J. Intern. Med.255(6), 698 (2004).
   Google Scholar
• Daly AF, Jaffrain-Rea ML, Ciccarelli A et al. Clinical characterization of familial isolated pituitary adenomas. J. Clin. Endocrinol. Metab.91(9), 3316–3323 (2006).
   PubMed Web of Science ®Google Scholar
• Vierimaa O, Georgitsi M, Lehtonen R et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science312(5777), 1228–1230 (2006).
   PubMed Web of Science ®Google Scholar
• Daly AF, Van Bellinghen JF, Khoo SK et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J. Clin. Endocrinol. Metab.92(5), 1891–1896 (2007).
   PubMed Web of Science ®Google Scholar
• Barlier A, Vanbellinghen JF, Daly AF et al. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J. Clin. Endocrinol. Metab.92(5), 1952–1955 (2007).
   PubMed Web of Science ®Google Scholar
• Cazabat L, Libè R, Perlemoine K et al. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur. J. Endocrinol.157(1), 1–8 (2007).
   PubMed Web of Science ®Google Scholar
• Georgitsi M, De Menis E, Cannavò S et al. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin. Endocrinol. (Oxf.)69(4), 621–627 (2008).
   PubMed Web of Science ®Google Scholar
• Beckers A, Vanbellinghen J-F, Boikos S et al. Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features. Presented at: 90th Annual Meeting of the Endocrine Society, San Francisco, CA, USA, 15–18 June 2008.
   Google Scholar
• Tichomirowa MA, Daly AF, Barlier A et al. High incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas. Presented at: 91st Annual Meeting, Endocrine Society Washington, DC, USA, 10–13 June 2009.
   Google Scholar
• Tichomirowa MA, Daly AF, Pujol J et al. An analysis of the role of cyclin dependent kinase inhibitor 1B (CDKN1B) gene mutations in 86 families with familial isolated pituitary adenomas (FIPA). Presented at: 91st Annual Meeting, Endocrine Society Washington, DC, USA, 10–13 June 2009.
   Google Scholar
• Beckers A, Daly AF. The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur. J. Endocrinol.157(4), 371–382 (2007).
   PubMed Web of Science ®Google Scholar
• Daly AF, Tichomirowa MA, Ebeling TML et al. An international collaborative study of the clinical characteristics and therapeutic responses in 92 pituitary adenoma patients with mutations of the aryl hydrocarbon receptor interacting protein gene. Presented at: 11th International Pituitary Congress Washington, DC, USA, 13–15 June 2009.
   Google Scholar
• Jaffrain-Rea ML, Angelini M, Gargano D et al. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr. Relat. Cancer16(3), 1029–1043 (2009).
   PubMed Web of Science ®Google Scholar
• Georgitsi M, Raitila A, Karhu A et al. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc. Natl Acad. Sci. USA104(10), 4101–4105 (2007).
   PubMed Web of Science ®Google Scholar
• Leontiou CA, Gueorguiev M, van der Spuy J et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J. Clin. Endocrinol. Metab.93(6), 2390–2401 (2008).
   PubMed Web of Science ®Google Scholar